RI
ALT icon

RTW Investments’s Altimmune ALT Stock Holding History

RTW Investments’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,334,940
Closed -$17.6M – 104
2020
Q3 		$17.6M Buy
+1,334,940
New +$26.7M 0.42% 53

Other funds holding ALT

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RTW Investments's ALT Position: Q4 2020 in Review

RTW Investments sold out of Altimmune (ALT) in Q4 2020, closing a stake of 1,334,940 shares — an estimated $17.6M sold.

RTW Investments first reported a position in ALT in Q3 2020 and held it in 1 quarter. The position peaked at $17.6M in Q3 2020. 88 funds tracked by Wall St. Rank hold ALT as of Q4 2020.

  • RTW Investments reported no remaining Altimmune position as of Q4 2020 after selling out during the quarter.
  • RTW Investments sold 1,334,940 Altimmune shares in Q4 2020, an estimated $17.6M.
  • RTW Investments first reported a position in Altimmune in Q3 2020 and held it in 1 quarter.
  • RTW Investments's Altimmune position peaked at $17.6M in Q3 2020.
  • 88 funds tracked by Wall St. Rank held Altimmune as of Q4 2020.

Based on RTW Investments's 13F filing for Q4 2020, filed 16 Feb 2021.